Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to "Cognitive effects of cell-derived and synthetically-derived Aβ oligomers" [Neurobiol. Aging 32 (2009) 1784-1794].

Neurobiology of aging·2026
Same author

Reengineering of Circularly Permuted Caspase-2 to Enhance Enzyme Stability and Enable Crystallographic Studies.

ACS chemical biology·2025
Same author

Retraction Note: A specific amyloid-β protein assembly in the brain impairs memory.

Nature·2024
Same author

An electrophilic fragment screening for the development of small molecules targeting caspase-2.

European journal of medicinal chemistry·2023
Same author

Aβ*56 is a stable oligomer that correlates with age-related memory loss in Tg2576 mice.

bioRxiv : the preprint server for biology·2023
Same author

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.

Journal of Alzheimer's disease : JAD·2023

Related Experiment Video

Updated: Jul 1, 2025

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
08:01

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

42.3K

Aβ∗56 is a stable oligomer that impairs memory function in mice.

Peng Liu1,2, Ian P Lapcinski1,2, Chris J W Hlynialuk1,2

  • 1N. Bud Grossman Center for Memory Research and Care, Minneapolis, MN 55455, USA.

Iscience
|March 4, 2024
PubMed
Summary

Amyloid-beta*56 (Aβ*56) oligomers impair memory. This study biochemically characterized Aβ*56, revealing its distinct peptide compositions across different mouse models, offering insights into Alzheimer

Keywords:
BiochemistryNeuroscience

More Related Videos

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

23.2K
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

18.2K

Related Experiment Videos

Last Updated: Jul 1, 2025

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
08:01

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

42.3K
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

23.2K
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

18.2K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Amyloid-beta (Aβ) oligomers are implicated in cognitive decline.
  • Aβ*56 is a specific soluble Aβ assembly linked to memory deficits.
  • The precise molecular composition of Aβ*56 has remained unclear.

Purpose of the Study:

  • To confirm the memory-impairing effects of Aβ*56.
  • To biochemically characterize the Aβ peptide forms within Aβ*56 across different transgenic mouse models.
  • To investigate the structural stability and properties of Aβ*56.

Main Methods:

  • Utilized antibodies targeting different Aβ forms and oligomers (A11).
  • Employed western blotting, immunoaffinity purification, and size-exclusion chromatography.
  • Analyzed brain extracts from Tg2576, 5xFAD, and APP/TTA mouse models.
  • Injected Aβ*56 into the hippocampus of wild-type mice.

Main Results:

  • Confirmed Aβ*56's memory-impairing properties.
  • Determined Aβ*56 composition varies: Aβ(1-40) in Tg2576, Aβ(1-42) in 5xFAD, and both in APP/TTA mice.
  • Characterized Aβ*56 as an SDS-stable, water-soluble, non-plaque-dependent oligomer.

Conclusions:

  • Aβ*56's molecular composition is model-dependent.
  • The stability and specific Aβ forms within Aβ*56 are key to its cognitive effects.
  • Aβ*56 is a valuable target for understanding the link between molecular structure and brain function in Alzheimer's disease.